You are not logged in.

BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide

Rosenthal, MA, Ashley, David and Cher, L 2004, BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide, Journal of Clinical Neuroscience, vol. 11, no. 4, pp. 374-375, doi: 10.1016/j.jocn.2003.01.002.

Attached Files
Name Description MIMEType Size Downloads

Title BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide
Author(s) Rosenthal, MA
Ashley, David
Cher, L
Journal name Journal of Clinical Neuroscience
Volume number 11
Issue number 4
Start page 374
End page 375
Total pages 2
Publisher Elsevier
Place of publication Amsterdam, The Netherlands
Publication date 2004-05
ISSN 0967-5868
Keyword(s) Adult
Aged
Antineoplastic Agents, Alkylating
Brain Neoplasms
Carmustine
Dacarbazine
Disease Progression
Dose Fractionation
Female
Follow-Up Studies
Glioma
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Treatment Outcome
Language eng
DOI 10.1016/j.jocn.2003.01.002
Field of Research 1103 Clinical Sciences
1109 Neurosciences
HERDC Research category CN.1 Other journal article
Copyright notice ©2004, Elsevier
Persistent URL http://hdl.handle.net/10536/DRO/DU:30070869

Document type: Journal Article
Collection: School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 10 times in TR Web of Science
Scopus Citation Count Cited 10 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 3 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Tue, 17 Mar 2015, 10:52:20 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.